Dialysis patients were more likely than transplant recipients to die from pre-existing cancers, whereas transplant recipients were more likely to die from de novo cancers.
Hardships greatest among younger cancer survivors vs patients without cancer history
Tachycardia significantly predicts mortality in lung cancer, leukemia, lymphoma, multiple myeloma
Large proportion of participants with newly diagnosed cancer learned of infection through study.
Standardized mortality ratio highest for cancers of lung, head and neck, testes, bladder, Hodgkin lymphoma.
Reduction in trial discussions, trial offers, trial participation seen with one or more comorbidities.
Health expenditure greater for person with 2 diseases simultaneously than for the diseases separately.
Socioeconomic inequalities are widening, but racial gap in cancer mortality narrowing slowly.
Mortality rate lower for habitually active patients and for those who started exercising after diagnosis
41% are not at all familiar with personalized medicine; only 5% say they are very familiar.
Risk for patients in rivaroxaban group reduced during the on-treatment period
Drug targets solid tumors with NTRK gene fusion without a known acquired resistance mutation
Second study shows no significant results for vitamin D supplementation vs placebo.
In addition to health care factors, issues outside of treatment may affect cancer death rates.
Higher risk seen with ACEIs vs angiotensin receptor blockers; risk linked to duration of use
Radiation dose not impacted with light or moderate use of skin treatments, regardless of beam energy, incidence
At 6 months, rates for provoked, unprovoked, cancer-related VTE are 6.8, 6.92, 9.06 per 100 person-years
From 2000 to 2015 screening for breast, cervical, and prostate cancers decreased significantly, whereas screening for colorectal cancer increased significantly.
High-dose monthly supplementation doesn't reduce risk of cancer among middle-aged and older adults.
Over 20 years, a 1-L reduction in alcohol intake was linked to 3.9 percent drop in overall cancer mortality.
Mortality risk linked to complementary medicine mediated by treatment refusal
Incidence rates decreased among men from 2008 to 2014, remained stable among women.
ICU and hospital mortality were lower for patients with cancer versus those without cancer.
Post-traumatic stress symptoms also linked to lower risk of readmission in hospitalized CA patients.
In subgroup analyses, reduced incidence of cancer seen in participants aged younger than 65 years.
Even among those exposed to high radiation doses, one-third not concerned about developing cancer.
Half of meds ID'd in expanded access programs treat cancer; others for metabolic, endocrine diseases
Even patients with mild chronic kidney disease were prevented from participating in clinical trials of drugs for bladder, breast, colorectal, lung, and prostate cancers.
Highest Healthy Eating Index scores associated with decreased overall and cancer-specific mortality.
From 2006 and 2016, smallest increase seen in high Sociodemographic Index countries.
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)